Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The papers propose a new method to prevent postoperative cerebrospinal fluid leakage. Doctors use the absorbable polyglycolic acid (PGA) and fibrin glue to repair in surgery, prevent cerebrospinal fluid leakage and reduce the necessity of postoperative lumbar drainage after surgery. This study will analyze the changes in cerebrospinal fluid leakage in patients with pituitary tumors and skull base tumors after surgery, and further understand the effectiveness of Neoveil , as the basis for the development of new treatments.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence

NCT01867268

Fibrolipoma of Filum Terminale Lipomyelomeningocele Split Cord Malformation +3 more

UNKNOWN PHASE2

Bed Rest on the Effect of CSF Leakage Repair After Transsphenoidal Pituitary Surgery

NCT05682391

Adenoma Pituitary CSF Leakage

ENROLLING_BY_INVITATION NA

CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap

NCT01932255

Cranial Nerve Diseases Facial Neuralgia Trigeminal Neuralgia +1 more

WITHDRAWN

Perioperative CSF Leak Management - an Opinion Study

NCT04124523

Cerebrospinal Fluid Leak

COMPLETED

Evaluation the Intracranial Volume Pressure Response in Increased Intracranial Pressure

NCT01126658

Brain Injury Intracranial Hypertension

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Neoveil, the main component, is polyglycolic acid (PGA), which is a kind of absorbable material, and is made into a soft and tension non-woven material by special processing with good tissue compatibility and degradability. In the human body, its strength will gradually decrease due to hydrolysis, and will eventually be absorbed and metabolized. In the process of absorption, at first its strength is reduced, then the mass will gradually decrease, and it will be completely absorbed after about 15 weeks. At present, the United States, Europe, Australia, China and South Korea have been marketed, it is applied to the spine , pituitary tumors , skull base tumors and aneurysm surgery,etc. inthe related field of Neurosurgery in foreign countries. It can prevent the leakage of cerebrospinal fluid, and reduce the postoperative hospital stay and the probability of complications after surgery. There is a license from the TFDA. In clinical, it can be used in the sutures of parts or fragile organs that do not need to be healed for a long time, such as the lung, liver, and digestive tract, by suture (thick slice and tube type) or adhesion (Sheet) In the tissue, it can strengthen the compressive ability of the local tissue, prevent the suture thread from splitting the suture tissue, prevent the lung tissue from leaking, reduce the blood and fluid leakage from the surgical site, and reduce the postoperative hospital stay and after the operation The complication rate .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pituitary Tumor Cerebrospinal Fluid Leakage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Using polyglycolic acid mesh

Group Type EXPERIMENTAL

polyglycolic acid(Neoveil)

Intervention Type DEVICE

This study plans to enroll patients with pituitary tumors who need to undergo surgical treatment according to current routine medical standards. After the tumor tissue is removed, the integrity of the spider web or skull base will be thoroughly checked by endoscopy during the operation to confirm whether there is any cerebrospinal fluid leakage. At the end of the operation, use a 100\*50\*0.15mm, green sheet-like Navi tissue repair patch, cut it aseptically to fit the size of the defect for repair (the common case is 2\*3.5cm defect), and place it on the spider web or skull base Tissue repair at the surgical site to prevent cerebrospinal fluid leakage.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

polyglycolic acid(Neoveil)

This study plans to enroll patients with pituitary tumors who need to undergo surgical treatment according to current routine medical standards. After the tumor tissue is removed, the integrity of the spider web or skull base will be thoroughly checked by endoscopy during the operation to confirm whether there is any cerebrospinal fluid leakage. At the end of the operation, use a 100\*50\*0.15mm, green sheet-like Navi tissue repair patch, cut it aseptically to fit the size of the defect for repair (the common case is 2\*3.5cm defect), and place it on the spider web or skull base Tissue repair at the surgical site to prevent cerebrospinal fluid leakage.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\. Patients with primary or recurrent pituitary tumors require endoscopic nasal surgery.

Exclusion Criteria

1. Patients with pituitary gland tumors who do not receive surgical treatment.
2. Patients with other brain tumors.
3. Patients allergic to polyglycolic acid (PGA).
4. Patients who have had previous radiation therapy or chemotherapy.

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No